This opportunity is no longer accepting applications.
grant PAR-23-157

Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)

This grant opportunity provides funding for clinical research projects aimed at exploring and developing an understanding of the neurobiological mechanisms behind substance use disorders (SUD). It supports projects that are in the exploratory or developmental stages and require larger budgets than typically allowed for under similar grant mechanisms. The focus is on fundamental brain function …

This Funding Opportunity Announcement (FOA) uses a R61/R33 Phased Innovation Award mechanism to support clinical research applications that are exploratory and developmental in nature and focus on understanding the neurobiological mechanisms underlying SUD, including fundamental brain function r…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute on Drug Abuse
Program: SBIR

Dates

Opportunity Released: April 10, 2023
Open for Submission: April 10, 2023
Submission Deadline: May 7, 2026
Application Window Closes: May 7, 2026

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.